Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Azithramycine
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Berg-Candolfi M and Candolfi E | Depression of the N-demethylation of erythromycin, azithromycin, clarithromycin and clindamycin in murine Toxoplasma infection. | 1996 | Int. J. Parasitol. | pmid:9024879 |
Sefton AM et al. | Azithromycin in the treatment of periodontal disease. Effect on microbial flora. | 1996 | J. Clin. Periodontol. | pmid:8951627 |
Griffith DE et al. | Varying dosages of rifabutin affect white blood cell and platelet counts in human immunodeficiency virus--negative patients who are receiving multidrug regimens for pulmonary Mycobacterium avium complex disease. | 1996 | Clin. Infect. Dis. | pmid:8953085 |
Brihmer C et al. | Efficacy and safety of azithromycin versus lymecyline in the treatment of genital chlamydial infections in women. | 1996 | Scand. J. Infect. Dis. | pmid:8953672 |
Van Bambeke F et al. | Interaction of the macrolide azithromycin with phospholipids. I. Inhibition of lysosomal phospholipase A1 activity. | 1996 | Eur. J. Pharmacol. | pmid:8957238 |
Montenez JP et al. | Interaction of the macrolide azithromycin with phospholipids. II. Biophysical and computer-aided conformational studies. | 1996 | Eur. J. Pharmacol. | pmid:8957239 |
Prescott LM | Macrolides, azalides, and streptogrammins. | 1996 | J Int Assoc Physicians AIDS Care | pmid:11363516 |
Currier J | Progress report: prophylaxis and therapy for MAC. | 1996 | AIDS Clin Care | pmid:11363599 |
Kuzman I et al. | Azithromycin in the treatment of pneumonias caused by Chlamydia spp: a retrospective study. | 1996 | Int J Clin Pharmacol Res | pmid:9172008 |
Old drug approved for MAC prevention. | 1996 | AIDS Alert | pmid:11363659 | |
Torres G | MAC prophylaxis revisited. | 1996 | GMHC Treat Issues | pmid:11363706 |
Antivirals key to MAC prevention regimen. | 1996 | AIDS Alert | pmid:11363722 | |
Marco M | Opportunistic infections in Vancouver. | 1996 | GMHC Treat Issues | pmid:11363841 |
Azithromycin effective in preventing MAC. | 1996 | AIDS Alert | pmid:11363857 | |
Segreti J et al. | In vitro activity of macrolides against intracellular Legionella pneumophila. | 1996 | Diagn. Microbiol. Infect. Dis. | pmid:8902407 |
Schouten JT and Whittemore S | Recent development in the treatment and prevention of disseminated Mycobacterium avium complex (MAC). | 1996 | STEP Perspect | pmid:11364267 |
Wondrack L et al. | Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides. | 1996 | Antimicrob. Agents Chemother. | pmid:8849266 |
Lode H et al. | Azithromycin--review of key chemical, pharmacokinetic and microbiological features. | 1996 | J. Antimicrob. Chemother. | pmid:8818841 |
Girard AE et al. | Correlation of increased azithromycin concentrations with phagocyte infiltration into sites of localized infection. | 1996 | J. Antimicrob. Chemother. | pmid:8818842 |
Girard D et al. | Influence of immunosuppression on the pharmacokinetics and pharmacodynamics of azithromycin in infected mouse tissues. | 1996 | J. Antimicrob. Chemother. | pmid:8818843 |
Foulds G et al. | The absence of an effect of food on the bioavailability of azithromycin administered as tablets, sachet or suspension. | 1996 | J. Antimicrob. Chemother. | pmid:8818844 |
Vaudaux BP et al. | Concentrations of azithromycin in tonsilar and/or adenoid tissue from paediatric patients. | 1996 | J. Antimicrob. Chemother. | pmid:8818845 |
Pukander J and Rautianen M | Penetration of azithromycin into middle ear effusions in acute and secretory otitis media in children. | 1996 | J. Antimicrob. Chemother. | pmid:8818846 |
Rodriguez AF | An open study to compare azithromycin with cefaclor in the treatment of children with acute otitis media. | 1996 | J. Antimicrob. Chemother. | pmid:8818847 |
O'Doherty B | An open comparative study of azithromycin versus cefaclor in the treatment of patients with upper respiratory tract infections. | 1996 | J. Antimicrob. Chemother. | pmid:8818848 |
Müller O | An open comparative study of azithromycin and roxithromycin in the treatment of acute upper respiratory tract infections. | 1996 | J. Antimicrob. Chemother. | pmid:8818849 |
Gris P | Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study. | 1996 | J. Antimicrob. Chemother. | pmid:8818850 |
Zachariah J | A randomized, comparative study to evaluate the efficacy and tolerability of a 3-day course of azithromycin versus a 10-day course of co-amoxiclav as treatment of adult patients with lower respiratory tract infections. | 1996 | J. Antimicrob. Chemother. | pmid:8818851 |
Laurent K | Efficacy, safety and tolerability of azithromycin versus roxithromycin in the treatment of acute lower respiratory tract infections. | 1996 | J. Antimicrob. Chemother. | pmid:8818852 |
Montero L | A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and/or soft tissue infections. | 1996 | J. Antimicrob. Chemother. | pmid:8818853 |
Nahata M | Drug interactions with azithromycin and the macrolides: an overview. | 1996 | J. Antimicrob. Chemother. | pmid:8818854 |
Treadway G and Pontani D | Paediatric safety of azithromycin: worldwide experience. | 1996 | J. Antimicrob. Chemother. | pmid:8818855 |
Carbon C et al. | Economic analysis of antibiotic regimens used in the treatment pharyngitis: a prospective comparison of azithromycin versus roxithromycin. | 1996 | J. Antimicrob. Chemother. | pmid:8818856 |
Worth S et al. | Quality control guidelines for amoxicillin, amoxicillin-clavulanate, azithromycin, piperacillin-tazobactam, roxithromycin, ticarcillin, ticarcillin-clavulanate, trovafloxacin (CP 99,219), U-100592, and U-100766 for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Results from multicenter trials. | 1996 | Diagn. Microbiol. Infect. Dis. | pmid:9147914 |
Hultén K et al. | New pharmacokinetic in vitro model for studies of antibiotic activity against intracellular microorganisms. | 1996 | Antimicrob. Agents Chemother. | pmid:9124830 |
Marchisio P et al. | Comparative study of once-weekly azithromycin and once-daily amoxicillin treatments in prevention of recurrent acute otitis media in children. | 1996 | Antimicrob. Agents Chemother. | pmid:9124831 |
Xu G et al. | Effect of macrolide antibiotics on macrophage functions. | 1996 | Microbiol. Immunol. | pmid:8865152 |
Wintermeyer SM et al. | Dirithromycin: a new macrolide. | 1996 | Ann Pharmacother | pmid:8893122 |
Waugh MA | Azithromycin in gonorrhoea. | 1996 | Int J STD AIDS | pmid:8652723 |
Young LS | Treatment and prophylaxis of Mycobacterium avium complex. | 1996 | Int J STD AIDS | pmid:8652724 |
Hoepelman IM | Human cryptosporidiosis. | 1996 | Int J STD AIDS | pmid:8652725 |
Okumura A and Kuno K | [Pharmacokinetic and clinical evaluation of azithromycin in pediatrics]. | 1996 | Jpn J Antibiot | pmid:8988411 |
McCutchan JA | Azithromycin in the prophylaxis of opportunistic infections in AIDS. | 1996 | Int J STD AIDS | pmid:8652726 |
Kobayashi Y et al. | [Clinical study of a macrolide antibiotic, azithromycin, in pediatric patients]. | 1996 | Jpn J Antibiot | pmid:8988412 |
Ridgway GL | Azithromycin in the management of Chlamydia trachomatis infections. | 1996 | Int J STD AIDS | pmid:8652727 |
Furukawa S and Okada T | [A clinical evaluation of azithromycin in the treatment of pediatric infection]. | 1996 | Jpn J Antibiot | pmid:8988413 |
Ballard RC et al. | Treatment of chancroid with azithromycin. | 1996 | Int J STD AIDS | pmid:8652728 |
Okada T et al. | [Pharmacokinetic and clinical evaluations of azithromycin in the pediatric field]. | 1996 | Jpn J Antibiot | pmid:8988414 |
Bowden FJ et al. | Pilot study of azithromycin in the treatment of genital donovanosis. | 1996 | Genitourin Med | pmid:8655160 |
Ishida Y et al. | [Pharmacokinetic and clinical evaluation of azithromycin in pediatric infections]. | 1996 | Jpn J Antibiot | pmid:8988415 |
Ohtsuka Y et al. | [Pharmacokinetic and clinical studies on azithromycin in children]. | 1996 | Jpn J Antibiot | pmid:8988416 |
Kohl PK et al. | Gonorrhoea: single-dose oral treatment. | 1996 | Curr. Probl. Dermatol. | pmid:8743257 |
Nickel P and Näher H | Nongonococcal urethritis. | 1996 | Curr. Probl. Dermatol. | pmid:8743259 |
Johnson RB | Azithromycin. | 1996 | Curr. Probl. Dermatol. | pmid:8743269 |
Caselli M et al. | A comparative trial of short term therapy with omeprazole plus either amoxycillin or azithromycin for Helicobacter pylori eradication. | 1996 | J. Antimicrob. Chemother. | pmid:8722557 |
MashkilleÄson AL | [The treatment of early syphilis today]. | 1996 | Ter. Arkh. | pmid:9045378 |
Falagas ME and Klempner MS | Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin. | 1996 | Clin. Infect. Dis. | pmid:8722936 |
Murphy GS et al. | Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in U.S. troops deployed to Thailand in 1994. | 1996 | Clin. Infect. Dis. | pmid:8722958 |
Luke DR et al. | Safety, toleration, and pharmacokinetics of intravenous azithromycin. | 1996 | Antimicrob. Agents Chemother. | pmid:8913468 |
Scorneaux B et al. | Effect of recombinant human gamma interferon on intracellular activities of antibiotics against Listeria monocytogenes in the human macrophage cell line THP-1. | 1996 | Antimicrob. Agents Chemother. | pmid:8723471 |
Olsen KM et al. | Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses. | 1996 | Antimicrob. Agents Chemother. | pmid:8913469 |
Havlir DV et al. | Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group. | 1996 | N. Engl. J. Med. | pmid:8676932 |
Kuo CC et al. | In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae. | 1996 | Antimicrob. Agents Chemother. | pmid:8913488 |
Aoyama T et al. | Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin. | 1996 | J. Pediatr. | pmid:8917247 |
Magid D et al. | Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis. | 1996 | Ann. Intern. Med. | pmid:8554247 |
Cammarota G et al. | Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin. | 1996 | Aliment. Pharmacol. Ther. | pmid:8971300 |
Pilotto A et al. | Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers. | 1996 | Aliment. Pharmacol. Ther. | pmid:8971305 |
Andenaes K et al. | Preoperative bacterial colonization and its influence on postoperative wound infections in plastic surgery. | 1996 | J. Hosp. Infect. | pmid:8971618 |
Pozniak A and Nelson MR | Against the proposition: all patients with advanced HIV disease should be offered rifabutin prophylaxis. | 1996 | Genitourin Med | pmid:8976832 |
Schwartz RA et al. | Bacillary angiomatosis in an HIV seronegative patient on systemic steroid therapy. | 1996 | Br. J. Dermatol. | pmid:8977724 |
O'Doherty B | Azithromycin versus penicillin V in the treatment of paediatric patients with acute streptococcal pharyngitis/tonsillitis. Paediatric Azithromycin Study Group. | 1996 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:8922571 |
Griffith DE et al. | Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus. | 1996 | Clin. Infect. Dis. | pmid:8922790 |
Chulig I | [Pharmacokinetic profile of azithromycin. Role in the treatment of genital Chlamydia infections]. | 1996 | Antibiot. Khimioter. | pmid:8929112 |
Kuznetsova SM | ["Sumamed in the treatment of urogenital infections"]. | 1996 | Antibiot. Khimioter. | pmid:8929115 |
Skripkin IuK et al. | [The problem of diagnosis and treatment of urogenital chlamydiosis in Russia]. | 1996 | Antibiot. Khimioter. | pmid:8929120 |
Vasil'ev MM and Gazarian IIu | [Clinico-laboratory evaluation of the effectiveness of azithromycin in the treatment of patients with Chlamydia and mixed Chlamydia-gonorrhea infections]. | 1996 | Antibiot. Khimioter. | pmid:8929122 |
Schaad UB and Heynen G | Evaluation of the efficacy, safety and toleration of azithromycin vs. penicillin V in the treatment of acute streptococcal pharyngitis in children: results of a multicenter, open comparative study. The Swiss Tonsillopharyngitis Study Group. | 1996 | Pediatr. Infect. Dis. J. | pmid:8878223 |
McLinn S and Williams D | Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media. | 1996 | Pediatr. Infect. Dis. J. | pmid:8878239 |
McCarty J | A multicenter, open label trial of azithromycin for the treatment of children with acute otitis media. | 1996 | Pediatr. Infect. Dis. J. | pmid:8878240 |
Aronovitz G | A multicenter, open label trial of azithromycin vs. amoxicillin/ clavulanate for the management of acute otitis media in children. | 1996 | Pediatr. Infect. Dis. J. | pmid:8878241 |
McLinn S | A multicenter, double blind comparison of azithromycin and amoxicillin/ clavulanate for the treatment of acute otitis media in children. | 1996 | Pediatr. Infect. Dis. J. | pmid:8878242 |
Cellesi C et al. | Susceptibility of macrolide and beta-lactam antibiotics of Streptococcus pyogenes strains isolated over a four-year period in central Italy. | 1996 | J Chemother | pmid:8808714 |
Khurana CM | A multicenter, randomized, open label comparison of azithromycin and amoxicillin/clavulanate in acute otitis media among children attending day care or school. | 1996 | Pediatr. Infect. Dis. J. | pmid:8878243 |
Powers JL | Properties of azithromycin that enhance the potential for compliance in children with upper respiratory tract infections. | 1996 | Pediatr. Infect. Dis. J. | pmid:8878244 |
Wenisch C et al. | Effect of single oral dose of azithromycin, clarithromycin, and roxithromycin on polymorphonuclear leukocyte function assessed ex vivo by flow cytometry. | 1996 | Antimicrob. Agents Chemother. | pmid:8878577 |
Yeates RA et al. | Interaction between midazolam and clarithromycin: comparison with azithromycin. | 1996 | Int J Clin Pharmacol Ther | pmid:8880291 |
Welsh L et al. | In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae. | 1996 | Antimicrob. Agents Chemother. | pmid:8787907 |
Mehaffey PC et al. | Evaluation of in vitro spectra of activity of azithromycin, clarithromycin, and erythromycin tested against strains of Neisseria gonorrhoeae by reference agar dilution, disk diffusion, and Etest methods. | 1996 | J. Clin. Microbiol. | pmid:8789046 |
Mashkilleyson AL et al. | Treatment of syphilis with azithromycin. | 1996 | Int J STD AIDS | pmid:8652720 |
Bauernfeind A et al. | Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogens. | 1995 Sep-Oct | Infection | pmid:8557398 |
Erdogru T et al. | The treatment of non-gonococcal urethritis with single dose oral azithromycin. | 1995 Sep-Oct | J. Int. Med. Res. | pmid:8529783 |
Haddix AC et al. | The cost effectiveness of azithromycin for Chlamydia trachomatis infections in women. | 1995 Sep-Oct | Sex Transm Dis | pmid:7502180 |
Sternon J et al. | Azithromycin compared with clarithromycin in the treatment of adult patients with acute purulent tracheobronchitis: a cost of illness study. | 1995 Nov-Dec | J. Int. Med. Res. | pmid:8746608 |
Höffler D et al. | Pharmacokinetics of azithromycin in normal and impaired renal function. | 1995 Nov-Dec | Infection | pmid:8655206 |
Hashisaki GT | Update on macrolide antibiotics. | 1995 May-Jun | Am J Otolaryngol | pmid:7661309 |
What's in the water? | 1995 Mar-Apr | Treat Rev | pmid:11362299 | |
Rifabutin for MAC questioned. | 1995 Jul-Aug | Posit Aware | pmid:11362571 | |
Amin NM and Breadon G | An open-label, noncomparative study to evaluate the efficacy, safety, and tolerability of azithromycin in the treatment of patients with acute sinusitis. | 1995 Jul-Aug | Clin Ther | pmid:8565033 |
Qadri SM et al. | Antibacterial activity of azithromycin against Brucella melitensis. | 1995 Jul-Aug | Chemotherapy | pmid:7555205 |
Nuovo J et al. | Cost-effectiveness analysis of five different antibiotic regimens for the treatment of uncomplicated Chlamydia trachomatis cervicitis. | 1995 Jan-Feb | J Am Board Fam Pract | pmid:7701965 |